Capitulo 1.   Tumores cervicales malignos de los tejidos blandos. Sarcomas y tumores de tejido graso

• Addison AK, Payne SR. Primary liposarcoma of bone. Case report. J Bone Joint Surg Am 1982; 64: 301-304.
• Alemán López O, Carreno Villareal M, Durán R, García Ortega F, Bonnin Otal J. Metástasis en parótida de liposarcoma de miembro inferior. Acta Otorrinolaringol Esp 1999;50:667-670.
• Anon. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet 1997;350:1647-1654.
• Anon. Recommendations for the reporting of soft tissue sarcomas. Association of Directors of Anatomic and Surgical Pathology. Mod Pathol 1998;11: 1257-1261.
• Batsakis JG. Tumors of the Head and Neck. Clinical and pathological considerations. 1979. Chapter 18, 363.
• Dal Cin P, Sciot, Panagopuolos I. Adittional evidence of a variant trasnlocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: a clinicopathologic features. J Pathol 1997;182;437-41.
• Fernández Fernández L, Hondler C, Tejero E, Pellicer JL, Ratia T, Alfaro J, Tieso A, Yagüe S. Liposarcoma bien diferenciado de tipo lipomatoide localizado en cuello y mediastino. Cirugía Española 1991;3:266-268.
• Fagan JJ, Myers EN, Barnes L. A parapharyngeal myxoid liposarcoma. The Journal of Laryngology and Otology 1999;113:179-182.
• Fletcher CD. Distinctive soft tissue tumors of the head and neck. Mod Pathol. 2002;15(3):324-30.
• Gialdini F, Frezza D, Alaggio R, Biscaro G. Liposarcoma del cavo orale: descrizione di un caso e revisiones della letteratura. Acta Otorhinol Ital 1995;15:12-116.
• Golledge J, Fisher C, Rhys-Evans Ph. Head and Neck Liposarcoma.Cancer 1995;76: 1051-58.
• Heslin MJ, Lewis JJ, Woodruff JM, Brennan MF. Core needle biopsy for diagnosis of extremity soft tissue sarcoma. Ann Surg Oncol 2007;4:425.
• Kransdorf MJ. Malignant Soft- Tissue tumors in a Large Referral Population: Distribution of Diagnoses by Age, Sex, and Location. AJR 1995;164:129-134.
• Kraus MD, Guillou L, Fletcher CD. Well Differentiated inflammatory liposarcoma an uncommon and easily overlooked variant of a common sarcoma. Am J Surg Pathol 1997;21:518-27.
• Mandell DL, Brandwein MS, Woo P, Som Pm, Biller HF, Urken ML. Upper Aerodigestive Tract Liposarcoma: Report on Four Cases and Literature Review. Laryngoscope 1999;109:1245-1252.
• Mouret P. Liposarcome de l’hypopharynx. A propos d’un cas avec revue de la littérature. Rev Laryngol Otol Rhinol 1999;120:39-42.
• Orvieto E, Furlanetto A, Laurino L, Dei Tos AP. Myxoid and round cell liposarcoma: a spectrum of myxoid adipocytic neoplasia. Semin Diagn Pathol 2001;18(4):238-49.
• Otte TH. Liposarcoma of the Head and Neck. Archives of Otorhinolaryngology 1981; 232:285-291.
• Reitan JB, Kaafhus O, Brennhoud IO, Sager EM, Stenwing AE, Talle K. Pronostic factors in liposarcoma. Cancer 1985;55:2482-2490.
• Rosai J, Akerman m, Dal Cin. Combined morphologic and karyotypic study of 59 atypycal lipomatous tumors. Evaluation of their relationship and differential diagnosis with other adipose tissue tumors ( a report of CHAMP Study Group). Am J surg Pathol 1996;20:1182-9.
• Ruiz Liso JM, Sanz Anquela JM, Arrinda Yeregui JM, Gimeno Esteras E. Liposarcoma mixoide de ala nasal. Actas Dermo-Sif 1987;6:417-420.
• Saddik M, Oldring DJ, Mourad WA. Liposarcoma of the Base of Tongue and Tonsillar Fossa. A Possibly Underdiagnosed Neoplasm. Arch Pathol Lab Med 1996;120: 292-295.
• Stewart MG, Schwartz MR, Alford BR. Atypical and Malignant Lipomatous Lesions of the Head and Neck. Arch Otolaryngol Head Neck Surg 1994;120:1151-1155.
• Townsend C. En: Sabiston Tratado de Cirugía. Sarcomas de partes blandas y tumores óseos.17ª Edición, 2005. pag 806- 807.

     Capítulo 2.   Tumores cervicales malignos del tejido conectivo.

• Allen PWMyxoid Tumors of soft tisúes. Pathol Annu 1980;12:133-192.
• Allen PW, Dymock RB, MacCormac LB. Superficial angiomyxomas with and without epithelial components. Am J Surg Pathol 1988;12:519-30.
• Allen PW, Dymock RB, MacCormac LB. "Superficial angiomyxomas with and epithelial components". Am J Pathol 1988; 12:519.
• AngervalLl, Kindblom LG, Merck C: Mixofibrosarcoma . A study of 30 cases. Acta Pathol Microbiol Scand 1977;85:127-140.
• Barnhill Raymond L, Mihm Martin C Jr: Cellular neurotekeoma. A distinctive variant of neurotekeoma minicking nevomelano tumors. Am J Clin Surg Pathol 1990;14(2): 113-120.
• Begin LR, Clement PB, Kirk ME: Aggressive angiomyxoma of pelvic soft parts: a clinicopathologic study of nine cases. Hum Pathol 1985;16:621-628.
• Fletcher JA, Kozakewich HP, Hoffer FA. Diagnostic relevant of clonal cytogenetic aberrations in malignant soft tissue tumours. N Engl J Med 1991;324;436-442.
• Frierson HF, Cooper PH. Myxoid variant of dermatofibrosarcoma protuberans. Am J Surg Pathol 1983;7:445-450.
• Graadt van Roggen JF, Hogendoorn PCW, Fletcher CD. Myxoid tumours of soft tissue. Histopathology 35, 291-312.
• Grossniklaus HE, McLean IW, Gillespie JJ. "Bilateral eyelid myxomas in Carney´s complex". Br J Ophthalmol. 1991; 75: 251.
• Jakubovic HR, Salama SS, Rosenthal D. "Multiple cutaneous focal mucinosis with hypothyroidism". Ann Int Med 1982;96:56.
• Johson WC, Helwig EB. "Cutaneus focal mucinosis: a clinicopathological and histochemical study". Arch Dermatol 1966;93:13.  
• Kempson RL, Fletcher CD, Evans HL, Hendrickson MR, Sibley RK. Tumors of the soft tissue . Atlas of tumor pathology. Fas 30. Bethesda 2001.
• Meis JM, Enzinger FM: Juxta-articular myxoma. A clinical and pathologic study of 65 cases. Hum Pathol 1992;23:639-646.
• Mentzel .T, Calonje E, Waden C. Myxofibrosarcoma. Clinicopathologic análisis of 75 cases with emphasis on the low grade variant. Am J Surg Pathol 1996;20.391-405.
• Mentzel T, Brown LF, Dvorak HF. The association between tumour progression and vascularity in mixofibrosarcoma and myxoid/roun cell liposarcoma. Virchows Arch 2001; 438(1):13-22.
• Miettinen M, Fetsch J. Collagenous fibroma (desmoplastic fibroblastoma): A clinicopathologic analysis of 63 cases of a distinctive soft tissue lesion with stellate-shaped fibroblasts. Hum Pathol 1998;29:676-682.
• Ninfo V, Montesco MC Myxoid tumors of soft tissues: a challenging pathological diagnosis. Adv Clin Path 1998;2(2):101-115.
• Paulus Werner, Jellinger Kurt, Pernecza Gedeon: Intraespinal neurotekeoma (nerve steath mixoma a report of two cases). Am J Clin Pathol 1991;95:511-516.
• Ruiz Macia JA, Guerao Ramírez MR, Serra Sevilla JA, Bas Bernal A: Tumor mixoide benigno de la vaina nerviosa. Patología 1987;20:310-312.
• Steeper TA, Rosai J: Agressive angiomyxoma of the female pelvis and perineum: report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm. Am J Surg Pathol 1983;7:463-475.
• Weiss SW, Brooks JSJ: Soft tissue tumors. Monographs in pathology. Georgia 1996.Weiis SW, Goldblum JR. Soft tissue tumors. Fourth edition.Mosby St. Louis 2001.

     Capítulos 3  Tumores cervicales malignos vasculares y nerviosos.

• Abdullah BH. Gingival and cutaneous angiosarcoma. J Oral Pathol Med 2000;29:410-20.
• Abrahamson T, Seabury M, Piette W. Cutaneous Angiosarcoma. Advances in Dermatology 2001;17:279-99.
• Azam M. Cutaneous angiosarcoma complicating morbid obesity. Arch Pathol Lab Med 2001;125(4):531-3.
• Breiteneder-Geleff S. Podoplanin-a specific marker for lymphatic endothelium expressed in angiosarcoma. Verh Dtsch Ges Pathol 1999;83:270-5.
• Brown LF Dezube BJ, Tognazzi K, et al. Expression of Tie 1, Tie 2 and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol 2000;156:2179-83.
• Brown M. Recognition and Management of unusual cutaneous tumors. Dermatol Clinics 2000;18:714-25.
• Busam KJ, Mentzel T, Colpaert C, Barnhill RL, Fletcher CD.:Atypical or worrisome features in cellular neurothekeoma. A study of 10 cases. Am J Surg Pathol 1998,22 (9):1067-1072.
• Caro MR, Stubenrauch CH, Jr. Hemangioendothelioma of the skin. Arch Dermatol Syph 1945;51:295-304.
• Cruz J, Popjristova-Popovaa E. Angiosarcoma de la cara y el cuero cabelludo. Estudio clínico-patológico. Rev Cub Oncolog 1995;1:123-5.
• Del Mar Sáez de Ocariz M. Angiosarcoma of the scalp. Int J Dermatol 1999; 38: 697-9.
• Demitsu T, Inoue T, Kakurai M, et al. Activation of mast cells within a tumor of angiosarcoma: ultraestructural study of five cases. J Dermatol 2002; 29: 280-9.
• Eiling S, Lischner S, Busch JO. Complete remission of a radioresistant cutaneous angiosarcoma of the scalp by sistemic treatment withliposomal doxorubicin. Br J Dermatol 2002;147:150-3.
• Enzinger FM, Weiss SW. Malignant vascular tumors. En: Soft tissue tumors. 2 ed. St. Louis: CV Mosby, 1988;545-54.
• Fedok FG. Angiosarcoma: current review. Am J Otolaryngol 1999; 20: 223-31.Fink-Puches R. Cutaneous angiosarcoma. Hautazrt: 2000;51:479-85.
• Fink-Puches R. No detection of Human Herpesvirus 8 in Different types of cutaneous angiosarcoma. Arch Dermatol 2000;41:213-18.
• Gallanger RL, Helwing EB: Neurote-keoma a bening cutaneous tumor of neural origin. Am J Clin Pathol 1980;74:759-764.
• Girod A. Cutaneous angiosarcoma of the head: three cases. Rev Stomatol Chir Maxillofac 2002;103:69-73.
• Guillot B, Raison-Peyron N, Acevedo M, et al. Angiosarcoma of the scalp and face: failure of an interferon alpha treatment. Eur J Dermatol 2000;10:300-302.
• Hallel-HaIevy D, Yerushalmi J. Grundwald M et al. Stewart-Treves syndrome in a patient with elephantiasis. J Am Acad Dermatol 1999;41:349-50.
• Hardell L, Reizenstein J, Johansson B, et al. Angiosarcoma of the scalp and use of a cordless (portable) telephone. Epidemiology 1999;10:785-6.
• Holden CA, Spittle MF, Wilson-Jones E. Angiosarcoma of the face and scalp. Prognosis and treatment. Cancer 1987;59:1046-57.
• Hudson CP, Hanno R, Callen JP. Cutaneous angiosarcoma in a site of healed herpes zoster. Ins J Dermatol 1984;23:404-7.
• Jund R. Rapidly progresing course of cutaneous angiosarcoma in the area of the head-neck. Laryngorhinootologie 1999;78:557-60.
• Kracker A. Multifocal angiosarcoma of the scalp: a case report and review of the literature. Ear Nose Throat J 1999;78:302-5.
• Lever W. Tumores vasculares en: Histopatología de la piel; 7º Ed. Philadelphia: J.B. Lippincott Company, 1990;662-65.
• Ludolph-Hauser D, Thoma-Greber E, Sander C et al. Mast cells in an angiosarcoma complicating Xeroderma pigmentosum in a 13 year old girl. J Am Acad Dermatol 2000; 43:900-2.
• Maddox JC, Evans HL. Angiosarcoma of skin and soft tissues: a study of forty-four cases. Cancer 1981;48:1907-21.
• Naito S, Shimizu K, Nakashima M et al. Overexpression of Ets-1 transcription factor in angiosarcoma of the skin. Pathol Res Pract 2000;196:103-9.
• Nielsen G, O´Connell JX, Rosenberg AE : Intramuscular myxoma. A clinicopathologic study of 51 cases with emphasis on hipercelular and hipervascular variants. Am J Surg Pathol 1998;22(10):1222-1227.
• Orchard G, Zelger B, Jones E, et al. An Inmunocytochemical assessment of 19 cases of cutaneous angiosarcoma. Histopathology 1996;28:235-40.
• Pathak MA, Fitzpatrick TB, Nghiem P, Agasshi DS. Geriatric Dermatology. Fitzpatrick's Der-matology in General Medicine, Fifth edition, New York; Mc Graw-Hill, 1999:1715-17.
• Pino Mo, Febrer I, Ledesma E, Aliaga A. Implicación del virus herpes humano tipo 8 en la etiopatogenia del Sarcoma de Kaposi. Act Sifiliogr 1999;90(10):489-98.
• Prieto V Shea Ch. Selected Cutaneous vascular neoplasms. A Review. Update Dermatopathol 1999;15:508-23.
• Repiso B, Pérez-Gil A, Argueta O, et al. Angiosarcoma de cara y cuero cabelludo. A propósito de un caso. Act Dermosifil 1999;90:104-108.
• Remick SC, Patnaik M, Ziran M. Human herpesvirus 8 associated disseminated angiosarcoma in an HIV-sernegative woman: report of a case and limited case-control virologic study in vascular tumors. Am J Med 2000;108:660-664.
• Rosai J, Sumner HW, Kostianovsky M. Angiosarcoma of the skin: a clinicopathologic and fine structural study. Hum Pathol 1976;7:83-109.
• Ruocco V, Schwartz R, Ruocco E. Lymphedema: An inmunologically vulnerable site for development of neoplasms. J Am Acad Dermatol 2002;47:124-7.
• Schommer M, Herbst R, Brodersen J, et al. Retiform hemangioendothelioma: Another tumor associated with human herpesvirus type 8. J Am Acad Dermatol 2000;42:290-2.
• Sondak V, Rees R. Skin, Angiosarcoma of the scalp: Surgical and nonsurgical treatment. Emedicine Dec 26, 2001.
• Spieth K, Gille J, Kaufmann R. Therapeutic efficacy of interferon alfa-2a and 13-cis-retinoic acid in recurrent angiosarcoma of the head. Arch Dermatol 1999;135:1035-7.
• Satoh T, Takahashi Y, Yokozeki H, et al. Cutaneous angiosarcoma with thrombocytopenia. J Am Acad Dermatol 1999;40:872-6.
• Sur RK. Angiosarcomas-Clinical profile, pathology and management. S Afr J Surg 2000;38:13-16.
• Tanioka M, Ikoma A, Morita K et al. Angiosarcoma of the scalp: absence of vascular endothelial cadherin in primary and metastasic lesions. Br J Dermatol; 144: 380-3.
• Verleysen A, Dewolf K, Geerts ML, Naeyaert JM. Angiosarcoma of the face and scalp. European Journal of Dermatology 2000;10:403-404.
• Ulrich L, Krause M, Brachmann A, et al. Succesful treatment of angiosarcoma of the scalp by intralesional cytokine therapy and surface irradiation. J Eur Acad Dermatol Venereol 2000;14:412-5.
• Wilson-Jones E. Malignant vascular tumors. Clin Exp Dermatol 1976;(1):287-312.
• Yamamoto T, Umeda T, Yokozeki H, Nishioka K. Expression of basic fíbroblast growth factor and its receptor in angiosarcoma. J Am Acad Dermatol 1999;41:127-9.
• Yamamoto T, Umeda T, Nishioka K. inmunohistological distribution of stem cell factor and kit receptor in angiosarcoma. Acta Derm Venereol 2000;80:443-5.
• Yamasaki O, Terao K, Asagoe K, et al. Koebner phenomenon on skin graft donor site in cutaneous angiosarcoma. Eur J Dermatol 2001;11:584-6.
• Zeltouni NC, Hanna S, Loree TR et al. Angiolymphoid hyperplasia with eosinophilia: a classic clinical presentation with histologic features of angiosarcoma. Dermatol Surg 2002;28:772-5.

     Capítulo 4.   Tumores cervicales malignos musculares y cartilaginosos.

• Ackerman LV. Extra-osseous localized non-neoplastic bone and cartilage formation (so-called myositis ossificans). J Bone Joint Surg 1958;40A:279- 298.
• Aigner T, Dertinger S, Vornehm SI, Dudhia J, von der Mark K, Kirchner T. Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms. Am J Pathol 1997;150:2133-2141.
• Aigner T, Unni KK. Is dedifferentiated chondrosarcoma a 'de-differentiated' chondrosarcoma? J Pathol 1999;189:445- 447.
• Fletcher CD, Unni K., Mertens F: Tumours of soft tissue and bone. WHO classification of tumours. Lyon 2002.

     Capítulo 5.   Tumores cervicales de diferenciación incierta.

• Abdul-Karim FW, el Naggar AK, Joyce MJ, Makley JT, Carter JR. Diffuse and localized tenosynovial giant cell tumor and pigmented villonodular synovitis: a clinicopathologic and flow cytometric DNA analysis. Hum Pathol 1992;23: 729-735.
• Albritton KH, Randall RL: Perspectivas para la terapia dirigida de sarcoma sinovial. J Pediatr Hematol Oncol 2005;27:219-222.
• Bergh P, Meis-kindblom JM, Gherlinzoni F, et al. Sarcoma sinovial: la identificación de los grupos de bajo y alto riesgo. Cancer 1999;85:2596-2607.
• Brecht IB, Ferrari A, Int-Veen C, et al. Resección amplia del sarcoma sinovial tratados por el grupo cooperativo alemán e italiano de sarcoma de tejidos blandos pediátricos: el debate sobre el papel de las terapias adyuvantes. Pediatr Blood Cancer, en prensa.Ferrari A, Casanova M, Massimino M, et al. Sarcoma sinovial: informe de una serie de 25 niños consecutivos a partir de una sola institución. Med Pediatr Oncol 1999;32:32-37.
• Ferrari A, Casanova M. Nuevos conceptos para el tratamiento del rabdomiosarcoma pediátrico, sarcomas de tejidos blandos. Expert Rev Anticancer Ther, 2005;5 (2),307-318.
• Ferrari A, Gronchi A, Casanova M, et al. Sarcoma sinovial: un análisis retrospectivo de 271 pacientes de todas las edades atendidos en una sola institución. Cáncer, 2004; 101:627:634.
• Frustaci S, Gherlinzoni F, De Paoli A, et al Quimioterapia adyuvante: para sarcomas de tejidos blandos en las extremidades y tronco en adultos: resultados de un ensayo aleatorio de cooperacion italiana. J Clin Oncol 2001;19:1238-1247.
• Gronchi A, Casali PG, Mariani L, et al. Situación de los márgenes quirúrgicos y el pronóstico de los sarcomas de tejidos blandos de adultos de las extremidades: una serie de 911 pacientes consecutivos tratados en una sola institución. J Clin Oncol, J Clin Oncol. 2005;23 (1):96-104.
• Guillou L, Coindre JM, Bonichon F, et al. Estudio comparativo del Instituto Nacional del Cáncer y la Federación Francesa de Centros de Cáncer. Sistemas de clasificación del grupo de Sarcoma en una población de 410 pacientes adultos con sarcoma de tejidos blandos. J Clin Oncol.1997;15:350-362.
• Guillou L, Benhattar J, Bonichon F, et al. El grado histológico, pero no SYT-SSX tipo de fusión, es un importante factor pronóstico en pacientes con sarcoma sinovial: análisis retrospectivo de un estudio multicéntrico, el. J Clin Oncol. 2004;22(20):4040-4050.
• Harmer MH. Clasificación TNM de los tumores pediátricos. Ginebra, Suiza, la UICC Unión Internacional Contra el Cáncer, 1982;23-28.
• Kawaguchi S, Wada T, Ida K, et al. Un ensayo de fase I de vacunación de SYT-SSX unión del péptido en los pacientes con sarcoma sinovial difusión. J Transl Med. 2005; 12; 3 (1):1. 
• Ladenstein R, Treuner J, Koscielniak E, et al. El sarcoma sinovial de la infancia y la adolescencia: informe de la CWS-81 alemán de estudio. Cancer 1993;71:3647-3655.
• Lewis JJ, Antonescu CR, Leung dhy, et al. Sarcoma sinovial: un análisis multivariable de factores pronósticos en 112 pacientes con tumores primarios localizados en la extremidad. J Clin Oncol 2000;18:2087-2094.
• Mancuso T, Mezzekani A, Riva C, et al. Análisis de las transcripciones de la fusión SYT-SSX y bcl-2 Estado de Fosforilación de expresión en el sarcoma sinovial. Lab Invest 2000;80:805-813.Maurer HM, Beltangady M, Gehan EA, et al. El Estudio del rabdomiosarcoma Intergrupo I: informe final. Cancer 1988;61:209-220.
• Mezzelani A, Mariani L, Tamborini E, et al. SYT-SSX genes de fusión y el pronóstico ensarcoma sinovial. Br J Cancer 2001;85:1535-1539.Okcu MF, Munsell M, Treuner J, et al. El sarcoma sinovial de la infancia y la adolescencia: Un estudio multicéntrico, el análisis multivariado de los resultados. J Clin Oncol 2003;21:1602-1611.
• Pappo AS, Fontanesi J, Luo X, et al. El sarcoma sinovial en niños y adolescentes: Hospital de Investigación de Niños St. Jude de la experiencia. J Clin Oncol 1994;12:2360-2366.
• Sarcoma Meta-analysis Collaboration. Quimioterapia adyuvante para el sarcoma resecable y localizado de tejidos blandos de los adultos: meta-análisis de los datos individuales. Lancet 1997;350:1647-1654.
• Spillane AJ, A'Hern R, Judson IR, et al. Sarcoma sinovial: Patologia clinica, la estadificación y la evaluación, Pronóstico. J Clin Oncol 2000;18:3794-3803.
• Spurrell, EL, Fisher C, Thomas JM, Judson IR. Factores pronósticos en el sarcoma sinovial avanzado: Un análisis de 104 pacientes atendidos en el Hospital Royal Marsden. Ann Oncol 2005;16:37-444.
• Tamborini E, Bonadiman L, Greco A, et al. Expresión del ligando activado y KIT derivado de las plaquetas del receptor del factor de crecimiento b receptores de la tirosina quinasa en el sarcoma sinovial. Clin Cancer Res. 2004;10:938-943.
• Thomas DG, Giordano TJ, Sanders D, et al. Expresión del receptor de la tirosina quinasa del receptor del factor de crecimiento y de HER-2/neu en el sarcoma sinovial. Cancer 2005;103 (4):830-808.
• Trassard M, Le Doussal V, Hacène K, et al. Factores pronósticos en el sarcoma sinoviallocalizado primario: Un estudio multicéntrico de 128 pacientes adultos. J Clin Oncol 2001;9:525-534.
• Weiss SW, Goldblum J: Los tumores malignos de tejidos blandos de tipo incierto, en Weiss SW, Goldblum JR (eds.): Enzinger y Weiss Tumores de tejidos blandos, St. Louis, Missouri: CV Mosby 2001, pp 1483-1571.

     Capítulo 6.   Enfermedad metastásica cervical.

• Barrie JR, Knapper WH, Strong EW. Cervical nodel metastases of unknown origin. Am J Surg 1970;120:466-470.
• Johnson JT, Muerrs EH, Bedetti CD et al. Cervical lymph node metatasses. Incidence and implications of extracapsular carcinoma. Arch Otolaryngol 1985;111:534-537.
• Kotuging C, Damjanov I. Branchial cleft carcinoma. Arch Oto Laryngol 1969;89:92-93.
• Martin H, Morfit HM. Cervical lymph node metastasis as the firet symptom of cancer. Sur. Gynecol Obstet 1944;78:133-159.

     Capítulo 7  Adenopatias mestastásicas cervicales de tumor primario desconocido.

• Battifora H: Recent progress in the immunohistochemistry of solid tumors. Semin Diagn Pathol 1984;251-71. [PUBMED]
• Califano J. Unknown primary head and neck scamous cell carcinoma: molecular identification of the site of origin. J Natl Cancer Inst 1999;91:599-604.
• Carlson LS, Fletcher GH, Oswald MJ: Guidelines for radiotherapeutic techniques for cervical metastases from an unknown primary. Int J Radiat Oncol Biol Phys 1986;12 (12):2101-10. [PUBMED]
• Colletier PJ. Postoperative radiation for squamous cell carcinoma metastasic to cervical lymph nodes from an unknown primary site: outcomes and patterns on failure. Head Neck 1998;20(8):674-81.
• Consensus conference. Magnetic resonance imaging. JAMA 1988;259 (14): 2132-8. [PUBMED]
• Constine LS: What else don't we know about the late effects of radiation in patients treated for head and neck cancer? Int J Radiat Oncol Biol Phys 1995;31 (2): 427-9. [PUBMED]
• Feinmesser R, Miyazaki I, Cheung R, et al.: Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration. N Engl J Med 1992;326 (1):17-21. [PUBMED] 
• Fernández JA. Metastasic squamous cell carcinoma in cervical lymph nodes from an unknown primary tumor: prognosis factors. Clin Otolaryngol 1998;23(2):158-63.
• Greven KM. Ocult primary tumors of the head and neck: lack of benefit from fdg-PET imaging. Cancer 1999;86(1):114-8.
• Hainsworth JD, Wright EP, Gray GF Jr, et al.: Poorly differentiated carcinoma of unknown primary site: correlation of light microscopic findings with response to cisplatin-based combination chemotherapy. J Clin Oncol 1987;5(8):1275-80. [PUBMED]
• Hanna W, Kahn HJ: The ultrastructure of metastatic adenocarcinoma in serous fluids. An aid in identification of the primary site of the neoplasm. Acta Cytol 1985;29 (3): 202-10. [PUBMED]
• Herrera GA, Reimann BE: Electron microscopy in determining origin of metastatic adenocarcinomas. South Med J 1984;77 (12):1557-66. [PUBMED]
• Head and neck sites. In: American Joint Committee on Cancer.: AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer, 2002, pp 17-88.
• Jons AS. Squamous carcinoma presenting as an enlarged cervical lymph node. Cancer 1993;72:1756-61. 9.
• Jungehulsing M. fdg-PET is a sensitive tool for the detection of ocult primary cancer with head and neck lymph node manifestation. Otolaringol Head Neck Surg 2000;123:294-301.
• Gabalski EC. Management of the unknown primary in patients with mtastasic cancer of the head and neck. Ear Nose Throat J 2000;79(4):306-13.
• Grau C. Cervical lymph node metastases from unknown primary tumors. Results from national survey by the Danish Society from Head and Neck Oncology. Radiother Oncol 2000;55(2):121-9.
• Lapeyre M. Cervical Lymph node metastasis from an unknown primary: is a tonsilectomy necessary? Int J Radiat Oncol Biol Phys 1999;39(2):291-6.
• Kulapaditharom B. Fluorescence-guided biopsy in the diagnosis of un unknown primary cancer in patients with metastasic cervical lymph nodes. Ann Otol Rhinol Laryngol 1999;108(7pt1):700-4.
• Lefebvre JL. Les adénopathies cervicales sans porte d´entrée. Ann Oto-Laryng (Paris) 1987;104:513-8.
• Mack Y, Parsons JT, Mendenhall WM, et al.: Squamous cell carcinoma of the head and neck: management after excisional biopsy of a solitary metastatic neck node. Int J Radiat Oncol Biol Phys 1993;25 (4):619-22. [PUBMED]
• Mackay B, Ordonez NG: The role of the pathologist in the evaluation of poorly differentiated tumors. Semin Oncol 1982;9 (4):396-415. [PUBMED]
• Madani I, Vakaet L, Bonte K, et al.: Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer. Int J Radiat Oncol Biol Phys 2008;71 (4):1158-66. [PUBMED]
• Martinez MJ. Malignant cervical adenopathies of unknown origin. Acta Otorrinolaringol Esp 1997;48(5):383-5.
• Marcial-Vega VA. Cervical metastasis from unknown primaries: radiotherapeutic management and appearance of subsequent primaries. Int J Rad Oncol Biol Phys 1990;19:919-28.
• Maulard C, Housset M, Brunel P, et al.: Postoperative radiation therapy for cervical lymph node metastases from an occult squamous cell carcinoma. Laryngoscope 1992;2 (8):884-90. [PUBMED]
• McMahon J. Neck dissection and ipsilateral radiotherapy in the management of cervical carcinoma from an unknown primary. Aust N Z J Surg 2000;70(4):263-8.
• Medini E. The management of metastasic squamous cell carcinoma in cervical lymph nodes from an unknown primary. Am J Clin Oncol 1998;21(2):121-5.
• Percodani J. Metastatic cervical adenopathies of unknown primary site. Long-term course. Ann Otolaryngol Chir Cervicofac 1996;113(4):212-8.
• Randall DA. Tonsillectomy in diagnosis of the unknown primary tumor of the head and neck. Otolaryngol Head Neck Surg 2000;122(1):52-5.
• Piquyet JJ. Les adénopaties cervicales malignes apparemment primitives. Lille Chirurgical 1975;30:8-14.
• Rege S, Maass A, Chaiken L, et al.: Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 1994;73 (12):3047-58. [PUBMED]
• Safa AA. The role of position emission tomography in occult primary head and neck cancers. Cancer J Sci Am 1999;5(4):214-8.
• Stokkel MP. The detecytion of unknown primary tumor in patients with cervical metástases by dual-head positron emission. Oral Oncol 1999;35(4):390-4.
• Thyss A, Schneider M, Santini J, et al.: Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck. Br J Cancer 1986;54 (5):755-60. [PUBMED]
• Turner SL, Tiver KW, Boyages SC: Thyroid dysfunction following radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 1995;31 (2): 279-83. [PUBMED]
• Weissler MC, Melin S, Sailer SL, et al.: Simultaneous chemoradiation in the treatment of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1992;118 (8):806-10. [PUBMED] 
• William S. Yhe unknown primary. Symposium on malignances of the head and neck. Volume eleven.